VR Logo

Teva Pharmaceutical Industries Limited (TEVA) download report


Healthcare | Drugs & Pharma

Teva Pharmaceutical Industries Limited (TEVA) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally.

IPO Date: 26-Mar-1990

Pres, CEO & Director: Mr. Kare Schultz

Exec. VP & CFO: Mr. Eliyahu Sharon Kalif

Listing: NYSE: TEVA

Country: Israel

Headquarters: Tel Aviv,

Website: https://www.tevapharm.com

Key Facts

Market cap: $12,310.56 Mln

Revenue (TTM): $11,627.00 Mln

Earnings (TTM): $-1,054.00 Mln

Cash: $2,058.00 Mln

Total Debt: $22,453.00 Mln

Insider's Holding: 1.50%

Liquidity: Low

52 Week range: $6.78 - 11.15

Shares outstanding: 1,110,560,000

10 Years Aggregate:

  • CFO: $32,418.00 Mln
  • EBITDA: $6,988.00 Mln
  • Net Profit: $-14,783.00 Mln

Stock Performance

Time Period Teva Pharmaceutical Industries Limited (TEVA) S&P BSE Healthcare* S&P Midcap 400*
YTD38.42-11.26-12.12
1 month49.035.347.64
3 months41.421.470.67
1 Year10.76-11.82-8.09
3 Years15.0022.769.06
5 Years-9.3210.867.40
10 Years-10.7212.2710.04
As on 09-Aug-2022 *As on 08-Aug-2022
Year Teva Pharmaceutical Industries Limited (TEVA) S&P Midcap 400 S&P BSE Healthcare
2021-16.9923.2120.87
2020-1.5311.8161.45
2019-36.4524.05-3.55
2018-18.54-12.43-5.89
2017-45.9614.450.49
2016-43.2018.73-12.88
201516.73-3.7115.06